Range of services

Interdisciplinary diagnostics and drug treatments:

• Acute leukemia
• Myelodysplastic syndromes
• Chronic myeloproliferative diseases
• Malignant lymphomas (Hodgkin’s disease, non-Hodgkin’s lymphoma)
• Multiple myeloma
• Gastrointestinal tumors
• Breast cancer
• Osteosarcoma and soft tissue sarcoma
• Renal cell cancer
• Rare tumors (e.g. adrenocortical cancer, neuroendocrine tumors)
• Tumor diseases of unknown primary tumor
• Benign hematological diseases (e.g. immunothrombocytopenia, hemolytic anemia, drug-induced disorders of the blood cell formation)

Specialist fields

• Risk-adapted therapeutic strategies for acute leukemia, malignant lymphoma and multiple myeloma within the framework of therapy optimization tests
• GMP-compliant production and, where appropriate, immunomagnetic selection of autologous blood stem cells
• High-dose chemotherapy followed by autologous blood stem cell transplant, e.g. for multiple myeloma and malignant lymphoma
• Interdisciplinary therapy for osteosarcoma and soft tissue sarcoma, including gastrointestinal stromal tumors
• Phase I, II and Ill studies of new therapeutic strategies (e.g. antibodies, signal transduction inhibitors, immunotherapy)
• Laboratory for hematological special diagnostics (incl. membership of the national competence network "Acute and Chronic Leukemia" as well as of European LeukemiaNet), international reference laboratory for immunophenotyping for acute leukemia (initial diagnosis, proof of minimal residual disease)
• Bone marrow diagnosis by means of cytological, cytochemical and immunocytochemical processes, proof of HLA-B27/HLA-DR4, immunological test of thrombocyte function